Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2021 08:00 ET | Source: NeuroPace, Inc.

NeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome

Feasibility IDE study will be the first to evaluate responsive neuromodulation for a severe and disabling childhood-onset epilepsy MOUNTAIN VIEW, Calif., June 30, 2021 (GLOBE NEWSWIRE) --...
June 03, 2021 07:00 ET | Source: NeuroPace, Inc.

NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance

MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
May 20, 2021 08:00 ET | Source: NeuroPace, Inc.

NeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021

MOUNTAIN VIEW, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
April 26, 2021 16:05 ET | Source: NeuroPace, Inc.

NeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

MOUNTAIN VIEW, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of...
April 21, 2021 20:45 ET | Source: NeuroPace, Inc.

NeuroPace, Inc. Announces Pricing of Initial Public Offering

MOUNTAIN VIEW, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of...

keyboard_arrow_left Previous Page